Latest Breaking News On - Corrs - Page 1 : comparemela.com

Abemaciclib/Fulvestrant Boosts PFS in HR+/HER2– Breast Cancer Post–CDK4/6i Progression

Vepdegestrant Plus Palbociclib Sustains Efficacy in Advanced ER+ Breast Cancer

Vepdegestrant plus palbociclib maintained clinical efficacy and safety in patients with pretreated, advanced ER-positive, HER2-negative breast cancer.

Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer

Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.

Corrs lawyer jumps to JWS

Julia Green commences as a special counsel at JWS' Sydney office

Experts Discuss Current Standards, Selection, and Uncertainties in Bladder and Renal Cancer Care

Experts delineate the latest developments and lingering questions in bladder and renal cancers, covering pivotal trials, emerging therapies, and optimal management approaches.